✦ LIBER ✦

HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients

✍ Scribed by Del Mastro, L; Bruzzi, P; Nicolò, G; Cavazzini, G; Contu, A; D'Amico, M; Lavarello, A; Testore, F; Castagneto, B; Aitini, E

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of Neo-adjuvant Sequ

✍ Alfonso Sánchez-Muñoz; Ana Maria García-Tapiador; Rosario Dueñas-García; Ana Jaé 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

HER-2 and choice of adjuvant chemotherap

✍ Soonmyung Paik; Chanheun Park 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 433 KB

HER2 expression and efficacy of preopera

✍ Fabrice Andre; Chafika Mazouni; Cornelia Liedtke; Shu-Wan Kau; Debby Frye; Marjo 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB

Feasibility and toxicity of dose-dense a

✍ Marjorie Zauderer; Sujata Patil; Arti Hurria 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 238 KB

Evaluation of the prognostic value of HE

✍ Ioannis Kostopoulos; Petroula Arapantoni-Dadioti; Helen Gogas; Savvas Papadopoul 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 406 KB

P103 Toxicity and tolerability of the an

✍ A. Jagiello-Gruszfeld; A. Lowczak; J. Zbrzezniak-Smilgiewicz; S. Szablowska-Siwi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB